The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 160.50
Bid: 152.00
Ask: 169.00
Change: 0.00 (0.00%)
Spread: 17.00 (11.184%)
Open: 160.50
High: 0.00
Low: 0.00
Prev. Close: 160.50
DIA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

6 Apr 2022 09:58

RNS Number : 4664H
Dialight PLC
06 April 2022
 

 

 

 

Diialight plc

(the "Company")

 

Director / PDMR Shareholdings

 

 

Options under the Dialight plc Annual Performance Bonus Plan ("APBP")

On 5 April 2022, Fariyal Khanbabi, Group Chief Executive Officer and Executive Director, was granted a Deferred Share Award ("Deferred Award") in the form of nil cost options that entitled her to receive 24,327 ordinary shares of 1.89 pence each in the Company in accordance with the rules of the APBP.

 

The Deferred Award will be exercisable in two equal tranches on or after 31 January 2024 and 31 January 2025, subject to continued employment at each date of vesting.

 

No consideration was paid for the grant of these awards and no consideration is due to be paid by Fariyal Khanbabi on the vesting of the awards. A mandatory two-year post-vesting holding period applies to the award.

 

The notifications below, which have been made in accordance with the requirement of the UK Market Abuse Regulation, provide further details.

 

Richard Allan

General Counsel & Company Secretary

DD: +44 (0) 203 058 3546

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

Details of PDMR / person closely associated

 a)

Name

Fariyal Khanbabi

 2.

Reason for the notification

 a)

Position / Status

Director - Group Chief Executive Officer

 b)

Initial notification / Amendment

Initial notification

 3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 a)

Name

Dialight plc

 b)

LEI

2138001AD31KKD29Z495

 4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1.89 pence each in Dialight plc

 

 

 

GB0033057794

 b)

 Nature of the transaction

Grant of a Deferred Share Award over 24,327 ordinary shares under the Dialight plc Annual Performance Bonus Plan

 c)

 Price (pence) and volume

Price(s)

Volume(s)

0.00

24,327

 d)

 Aggregated information

- Aggregated volume

 

- Price (pence)

 

Not applicable - single transaction

 e)

 Date of the transaction

5 April 2022

 f)

 Place of the transaction

Outside a trading venue

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUQACUPPURQ
Date   Source Headline
19th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 202411:00 amRNSAdmission of New Shares
12th Mar 20245:55 pmRNSHolding(s) in Company
12th Mar 20244:56 pmRNSHolding(s) in Company
26th Feb 20242:39 pmRNSDirector/PDMR Shareholding
19th Feb 20249:16 amRNSDirectorate Change
19th Feb 20247:00 amRNSStatement re second interim results
16th Feb 20247:00 amRNSDirectorate Change
30th Jan 20247:00 amRNSCFO Appointment
30th Jan 20247:00 amRNSTrading Update
2nd Jan 20247:00 amRNSSanmina Litigation
29th Nov 20231:04 pmRNSSanmina Litigation
7th Nov 20235:40 pmRNSHolding(s) in Company
7th Nov 20235:24 pmRNSHolding(s) in Company
7th Nov 20233:52 pmRNSHolding(s) in Company
1st Nov 202312:03 pmRNSPDMR Shareholding
1st Nov 202311:50 amRNSTotal Voting Rights and Capital
1st Nov 202311:15 amRNSBlock listing Interim Review
31st Oct 20234:32 pmRNSHolding(s) in Company
27th Oct 202312:05 pmRNSResults of General Meeting
4th Oct 202311:52 amRNSCirc re. Related Party Transaction
27th Sep 20237:00 amRNSResult of Equity Issue
26th Sep 20235:07 pmRNSREX Retail Offer
26th Sep 20235:05 pmRNSProposed Placing and Retail Offer
18th Sep 202312:25 pmRNSStatement re Update on Financing
18th Sep 20237:00 amRNSDirector Change
18th Sep 20237:00 amRNSUnaudited Half Year Results 2023
26th Jun 20237:00 amRNSDirectorate Change and Notice of Results
8th Jun 20237:00 amRNSDirector/PDMR Shareholding
7th Jun 20237:00 amRNSDirectorate Changes
16th May 20235:47 pmRNSResult of AGM
16th May 20237:00 amRNSAGM Trading Update
27th Apr 20237:00 amRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSDirector/PDMR Shareholding
14th Apr 20231:03 pmRNSDirector/PDMR Shareholding
12th Apr 202312:30 pmRNSNotice of AGM
6th Apr 20232:35 pmRNSTotal Voting Rights
6th Apr 20232:20 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSDirectorate Change
3rd Apr 20231:03 pmRNSBlock listing Interim Review
3rd Apr 20237:00 amRNSAnnual Financial Report
30th Mar 20237:00 amRNSDirectorate Change
27th Mar 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSDirectorate Change
15th Mar 20235:14 pmRNSDirector Declaration
15th Mar 20237:00 amRNSSanmina Litigation
13th Jan 20237:00 amRNSDirectorate Change
13th Jan 20237:00 amRNSTrading Statement
5th Jan 20234:40 pmRNSSecond Price Monitoring Extn
5th Jan 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.